Global Bioenergies recently went public on the NYSE Euronext, taking in €6.6 million (about $9 million) for a valuation of about $56 million. The company has developed a microorganism capable of excreting isobutene, an olefin that is a precursor for many important fuels (including gasoline additives...
This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!
News Commentary | May 13, 2021
With an estimated transaction value of $100 million, Ingredion will get exclusive license to sell and market Amyris' Reb M sweetener technology under this agreement. Additionally, Ingredion will also get a minority stake in Amyris' new production facility in Brazil, to be completed by Q4 2021. ... Not part of subscription
News Commentary | July 08, 2021
L Catterton and DisruptAD, the venture capital arm of ADQ, led this Series B round, with participation from other corporate strategic investors like Thai Union Group, Cargill, and CJ CheilJedang, among others. Aleph Farms will use this funding to scale up cell‑based beef steak production and to ... Not part of subscription
News Commentary | July 14, 2021
Operating as Clariant IGL Specialty Chemicals, the JV combines India Glycols' renewable bio‑EO derivatives business with Clariant's Industrial & Consumer Specialties business in India, Sri Lanka, Bangladesh, and Nepal. This partnership isn't too surprising given the rise in demand for "eco‑... Not part of subscription